54
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IKKβ regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vascular endothelium provides a selective barrier between the blood and tissues, participates in wound healing and angiogenesis, and regulates tissue recruitment of inflammatory cells. Nuclear factor (NF)-κB transcription factors are pivotal regulators of survival and inflammation, and have been suggested as potential therapeutic targets in cancer and inflammatory diseases. Here we show that mice lacking IKKβ, the primary kinase mediating NF-κB activation, are smaller than littermates and born at less than the expected Mendelian frequency in association with hypotrophic and hypovascular placentae. IKKβ-deleted endothelium manifests increased vascular permeability and reduced migration. Surprisingly, we find that these defects result from loss of kinase-independent effects of IKKβ on activation of the serine-threonine kinase, Akt. Together, these data demonstrate essential roles for IKKβ in regulating endothelial permeability and migration, as well as an unanticipated connection between IKKβ and Akt signalling.

          Abstract

          IKK kinases activate nuclear factor-κB, and the activated form of this transcription factor is found in endothelial cells in diseased tissue. In this study, mice lacking IKKβ in the endothelium are generated, and it is shown that defects in endothelial cell function are both IKK kinase activity dependent and independent.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          IKK-beta links inflammation to obesity-induced insulin resistance.

          Inflammation may underlie the metabolic disorders of insulin resistance and type 2 diabetes. IkappaB kinase beta (IKK-beta, encoded by Ikbkb) is a central coordinator of inflammatory responses through activation of NF-kappaB. To understand the role of IKK-beta in insulin resistance, we used mice lacking this enzyme in hepatocytes (Ikbkb(Deltahep)) or myeloid cells (Ikbkb(Deltamye)). Ikbkb(Deltahep) mice retain liver insulin responsiveness, but develop insulin resistance in muscle and fat in response to high fat diet, obesity or aging. In contrast, Ikbkb(Deltamye) mice retain global insulin sensitivity and are protected from insulin resistance. Thus, IKK-beta acts locally in liver and systemically in myeloid cells, where NF-kappaB activation induces inflammatory mediators that cause insulin resistance. These findings demonstrate the importance of liver cell IKK-beta in hepatic insulin resistance and the central role of myeloid cells in development of systemic insulin resistance. We suggest that inhibition of IKK-beta, especially in myeloid cells, may be used to treat insulin resistance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis

            The IκB kinase (IKK) complex is composed of three subunits, IKKα, IKKβ, and IKKγ (NEMO). While IKKα and IKKβ are highly similar catalytic subunits, both capable of IκB phosphorylation in vitro, IKKγ is a regulatory subunit. Previous biochemical and genetic analyses have indicated that despite their similar structures and in vitro kinase activities, IKKα and IKKβ have distinct functions. Surprisingly, disruption of the Ikkα locus did not abolish activation of IKK by proinflammatory stimuli and resulted in only a small decrease in nuclear factor (NF)-κB activation. Now we describe the pathophysiological consequence of disruption of the Ikkβ locus. IKKβ-deficient mice die at mid-gestation from uncontrolled liver apoptosis, a phenotype that is remarkably similar to that of mice deficient in both the RelA (p65) and NF-κB1 (p50/p105) subunits of NF-κB. Accordingly, IKKβ-deficient cells are defective in activation of IKK and NF-κB in response to either tumor necrosis factor α or interleukin 1. Thus IKKβ, but not IKKα, plays the major role in IKK activation and induction of NF-κB activity. In the absence of IKKβ, IKKα is unresponsive to IKK activators.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

              Nuclear factor-kappa B (NF-kappaB)/Rel transcription factors play an important role in the inducible regulation of a variety of genes involved in the inflammatory and proliferative responses of cells. The present study was designed to elucidate the implication of NF-kappaB/Rel in the pathogenesis of atherosclerosis. Activation of the dimeric NF-kappaB complex is regulated at a posttranslational level and requires the release of the inhibitor protein IkappaB. The newly developed mAb alpha-p65mAb recognizes the IkappaB binding region on the p65 (RelA) DNA binding subunit and therefore selectively reacts with p65 in activated NF-kappaB. Using immunofluorescence and immunohistochemical techniques, activated NF-kappaB was detected in the fibrotic-thickened intima/media and atheromatous areas of the atherosclerotic lesion. Activation of NF-kappaB was identified in smooth muscle cells, macrophages, and endothelial cells. Little or no activated NF-kappaB was detected in vessels lacking atherosclerosis. Electrophoretic mobility shift assays and colocalization of activated NF-kappaB with NF-kappaB target gene expression suggest functional implications for this transcription factor in the atherosclerotic lesion. This study demonstrates the presence of activated NF-kappaB in human atherosclerotic tissue for the first time. Atherosclerosis, characterized by features of chronic inflammation and proliferative processes, may be a paradigm for the involvement of NF-kappaB/Rel in chronic inflammatory disease.
                Bookmark

                Author and article information

                Journal
                Nat Commun
                Nature Communications
                Nature Publishing Group
                2041-1723
                May 2011
                17 May 2011
                : 2
                : 318
                Affiliations
                [1 ]simpleThe Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, Massachusetts 02215, USA.
                [2 ]simpleTissue Engineering and Regenerative Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, USA.
                [3 ]simpleCardiovascular Division, MGH, Harvard Medical School , Boston, Massachusetts 02114, USA.
                [4 ]simpleWellman Center for Photomedicine, Massachusetts General Hospital (MGH), Harvard Medical School , Boston, Massachusetts 02114, USA.
                [5 ]simpleCenter for Immunology and Inflammatory Diseases MGH, Harvard Medical School , Charlestown, Massachusetts 02129, USA.
                [6 ]simpleDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, Massachusetts 02215, USA.
                [7 ]simpleDepartment of Pharmacology, UCSD , San Diego, California 92093, USA.
                [8 ]Present addresses: Department of Clinical Innovative Medicine, Translational Research Center, Kyoto University Faculty of Medicine, Kyoto 606-8507, Japan (N.A.); Department of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA (S.S.); Department of Regenerative Medicine and Transplantation, Fukuoka University Faculty of Medicine, Fukuoka 814-0180, Japan (S.K.); Cardiovascular Translational Medicine, Novartis Institute for Biomedical Research, Cambridge, Massachusetts 02139, USA (S.Y.F.); Arsenal Medical, Watertown, Massachusetts 02472, USA (P.Z.).
                Author notes
                Article
                ncomms1317
                10.1038/ncomms1317
                3113230
                21587235
                e8cf5fe4-560f-4682-9ebc-fb1895d7d25d
                Copyright © 2011, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

                This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

                History
                : 29 November 2010
                : 18 April 2011
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article